help + privacy policy + contact us + links + home
 
About APhACareerse-CommunitiesMeetingsPublicationsJoin APhA
Drug News  

APhA2010 Annual Meeting Washington DC

APhA CEO Blog

APhA 
Foundation


Print this page

Pharmacy News Archives: Previous Years     2008        2007        2006        2005       

News: Current Year (2009)

November

›› H1N1 with travelers as they head home for the holidays
›› Single lot of Sinex VapoSpray recalled
›› H1N1 influenza infects 22 million Americans in first 6 months, estimates CDC
›› Inhaled corticosteroids: Risks outweigh benefit in COPD
›› Dedication: Pharmacy’s classic space on the National Mall
›› Guidelines for compounding oseltamivir oral suspension issued by FDA
›› APhA holds first Veterans Day ceremony in renovated headquarters
›› HIV vaccine shows a modest benefit in reducing transmission
›› Emergency use of peramivir approved
›› Antivirals good option in many cases, says CDC
›› One dose of 2009 H1N1 vaccine will protect most pregnant women
›› Survey: Frontline pharmacists fighting flu fears
›› Depression: Pharmacists can help through collaborative care
›› Cardiac resynchronization therapy for patients with asymptomatic mild heart failure
›› FDA issues guidance to pharmacists on Tamiflu compounding and updates emergency use Q&A
›› Encourage pneumococcal vaccine, as appropriate, in patients for whom H1N1 vaccine is indicated
›› Deadline extended: One to One Counseling Recognition Program: Honoring exemplary patient care
›› CDC reports shortages of H1N1, seasonal influenza vaccine
›› Emergency use of oseltamivir beyond expiration dating
 
October
›› Buyer beware: Emergence of fraudulent H1N1 influenza products on the Internet
›› MTM, health care reform discussed at high-level meeting of APhA, CMS
›› Treatment of early RA with infliximab is beneficial
›› Hormonal therapy for prostate cancer may increase risk of death in men with CAD
›› Summarized billing recommendations for 2009 H1N1 vaccine
›› Mediterranean-style diets for patients with type 2 diabetes
›› Combination lipid-lowering therapy no better than high-dose statin monotherapy
›› CDC reports oseltamivir oral suspension shortages
›› USP Council of Experts call for candidates
›› Myth versus reality: What to tell patients about influenza vaccine
›› Long-term antipsychotic use reduces mortality in schizophrenia
›› Consumer med-disposal Web page launched
›› Childhood deaths from S. pneumoniae, H. influenzae high in developing countries
›› Tylenol products stolen in Jacksonville
›› Use warfarin cautiously in patients receiving hemodialysis
›› Ask the Expert: Roster billing for H1N1 vaccine administration
›› CDC update: Available 2009 H1N1 vaccine nears 7 million doses
›› CMS clarifies Medicare Part D fraud, waste, and abuse training requirement
›› Rasagiline may slow progression of Parkinson's disease
›› Influenza A (H1N1) vaccine studies published
›› AHRQ releases blood thinner safety video and brochure
›› CDC provides update, addresses public concerns regarding H1N1 influenza
›› Optimistic drug message improves placebo effect in asthma
›› Drug resistance testing improved survival in HAART-experienced patients
›› CDC transitions from planning to implementation of 2009 H1N1 vaccine
 
September
›› Aspirin use associated with lower colorectal cancer mortality
›› DASH diet may prevent development of diabetes in white patients
›› Pregnant women and 2009 H1N1: Resources from CDC
›› Safer colchicine dosing regimen approved
›› Ask the Expert: Addressing concerns regarding adjuvant use in seasonal and 2009 H1N1 vaccines
›› Drugs with anticholinergic properties harmful in the elderly
›› Updated influenza antiviral drug recommendations provided by CDC, FDA
›› Dabigatran for atrial fibrillation
›› Progesterone does not prevent preterm birth in twin pregnancy
›› Erythromycin ophthalmic ointment shortage
›› CDC provider agreement clarification: Role of medical directors
›› State framework outlined on pharmacy administration of H1N1 vaccine
›› Four H1N1 influenza vaccines licensed by FDA
›› Early vaccination against influenza, experts offer a review of the evidence
›› Additional efficacy and safety data for tiotropium released
›› Thromboembolism and oral contraceptives
›› Promising evidence for one-dose H1N1 vaccination schedule
›› 2009 H1N1 influenza vaccine distribution and administration: Current best information
›› H1N1 vaccine trial in pregnant women begins this week
›› Antivirals and 2009 H1N1 influenza: Updated guidance provided by CDC
›› HHS, CDC share important H1N1 influenza updates
›› Lifestyle modifications: A key component to preventing CV disease
›› Orlistat: No definite association with liver injury
›› Statin use not associated with decreased risk of community-acquired pneumonia
›› Chinese herbal remedy may be better than sulfasalazine for active rheumatoid arthritis
›› Treatment failure with dapsone/ferrous oxalate–minocycline interaction?
 
August
›› Elevated lipoprotein(a) levels associated with MI risk
›› Stepped-dose efavirenz reduces neuropsychiatric events
›› Golimumab effective for RA when other TNF-alpha inhibitors fail
›› Pemetrexed for maintenance treatment of metastatic lung cancer
›› Study may link insulin glargine and breast cancer
›› Proposed optimal intensity of anticoagulation
›› Cervarix protects against five types of cervical cancer–causing viruses
›› Prime Therapeutics PBM able to slow drug spending increases
›› More than 35,000 cartons of albuterol sulfate stolen
›› Grand jury indicts Oklahoma pharmacist and Board of Health member on felony drug charges
›› Prasugrel: The newest platelet inhibitor has arrived
›› New asthma assessment guidelines released
 
July
›› Rebound acid hypersecretion a concern after withdrawal of PPI therapy
›› Poor adherence to preventive asthma medication in teenagers
›› GMA airs news alert about therapeutic substitution
›› CDC names target groups, priorities for novel H1N1 influenza vaccine
›› Sildenafil trial stopped 1 year early because of safety concerns
›› Prescription misuse among adolescents
›› CDC presents H1N1 update
›› AGS guideline updated for persistent pain in older persons
›› FDA alerts pharmacists to July 9 theft of sanofi-aventis drug products
›› Sodium citrate versus heparin sodium locks in patients on hemodialysis
›› Health care providers need to educate about the dangers of vaccination refusal
›› Feds reassure nation on novel H1N1 flu vaccine
›› Today’s obesity epidemic linked to 1800s TB pandemic?
›› Study evaluates enoxaparin dosing in obese patients
›› One-dose emergency contraceptive approved by FDA
›› Value of aspirin for primary prevention should be weighed carefully
›› Teriparatide superior to alendronate for glucocorticoid-induced osteoporosis
›› Studies suggesting potential link between insulin glargine and cancer prompt call for further research
›› Acetaminophen must be made safer, FDA panelists agree
›› Menighan takes helm at APhA
 
June
›› Intensifying diabetes therapy improves A1C without adversely affecting health status
›› Maine legislature approves pharmacist immunization
›› Do PPIs and H2-blockers increase the risk of hip fractures?
›› Florida, Michigan launch electronic drug, health programs
›› Safety, efficacy of individualized LMWH bridging therapies
›› Outbreak of H1N1 in the United States
›› Folic acid fortification may prevent severe congenital heart defects
›› Insulin detemir alert issued by FDA
›› PSA screening may reduce death but leads to overdiagnosis
›› Manufacturers to introduce dextromethorphan educational icon
›› Opioid options explored at FDA REMS meeting
›› Creating a successful therapeutic relationship with patients with chronic conditions
 
May
›› Antidepressants linked to type 2 diabetes
›› Bevacizumab now approved for recurrent glioblastoma
›› Additional data confirm clopidogrel–PPI interaction
›› Vitamin D3 supplementation decreases PTH levels in CKD
›› ACC/AHA revise heart failure guidelines
›› Report from ‘drug czar’ finds rising admissions, deaths from controlled substance prescriptions
›› New data published on Vinca alkaloid drug interactions
›› Rosuvastatin reduces risk of venous thromboembolism
›› Modafinil’s effects on dopamine
›› Higher infliximab dose fails to improve clinical endpoints in patients with RA
›› Repeat and higher-intensity smoking cessation interventions best
›› What is the optimal CD4 count to start antiretroviral therapy?
 
April
›› Fresh broccoli sprouts improve H. pylori symptoms
›› Warnings beefed up on OTC analgesics, antipyretics
›› Copaxone theft reported
›› Meds mobilized for swine flu outbreak
›› Metformin reduces macrovascular, but not microvascular disease
›› Mepolizumab for eosinophilic asthma
›› APhA helps VA secure Senate briefing
›› Chronic pain associated with inadequate Vitamin D levels
›› Delegates debate, vote on Association policy
›› APhA Political Leadership Breakfast highlights health care reform
›› Pharmacogenomics takes San Antonio by storm
›› Student pharmacists inspired by Joey Cheek
›› Herbal and dietary supplements require special MTM
›› Annual Meeting attendees updated on the latest infectious disease information
›› Samuel Kalman, past APhA Honorary President, dies
 
March
›› Renal function influences warfarin effects
›› Gestational hypertension more common in women taking SSRIs
›› New data on PPI-clopidogrel interaction
›› One medication information document favored at recent FDA meeting
›› Cytomegalovirus vaccine shows promise
›› Study reports low use of electronic health records in U.S. hospitals
›› Placebo as effective as low-dose vitamin K for warfarin overdoses
›› Ciprofloxacin-resistant Neisseria meningitidis present in United States
›› Homer George: Father of Poison Prevention Week
›› Inadequate anticoagulation common in patients with AF at high risk for stroke
›› Endocarditis guidelines need to be updated
›› Febuxostat for hyperuricemia in patients with gout
›› Once-daily antiretroviral regimens increase adherence
›› New diagnosis provides chance to improve health behavior habits
›› Male fertility problems not observed during infliximab treatment
›› Role of 5-alpha-reductase inhibitors for prostate cancer chemoprevention
›› Genetic information improves warfarin dosing for some
›› Still time to vaccinate
›› Liraglutide: The next GLP-1 analogue for type 2 diabetes?
›› Most medication alerts overridden by clinicians
 
February
›› Lack of compliance to osteoporosis management guidelines
›› Argatroban for heparin-induced thrombocytopenia
›› High-dose inhaled corticosteroids vs. long-acting beta-agonists for uncontrolled asthma
›› Green tea may antagonize bortezomib anticancer effects
›› PCV7 reduces incidence of pneumococcal meningitis
›› Outcomes data lacking for chronic hepatitis B in adults
›› FDA looking to add REMS for certain opioids
›› Pneumococcal vaccine recommended for adult cigarette smokers
›› Predictors of antipsychotic medication-induced weight gain
›› Combination therapy effective for IgA nephropathy
›› FDA Advisory Committees vote to ban propoxyphene products
›› Trimethoprim versus cranberry extract for UTI prevention
 
January
›› KRAS gene mutation testing strongly recommended by ASCO
›› New evidence-based IBS recommendations released
›› Understanding cardiovascular risks in patients with HIV
›› Overseas debate on availability of oral contraceptives
›› Exploring pneumococcal vaccination in elderly adults
›› Risk of major drug interactions among older adults in community
›› Smoking associated with colorectal cancer
›› Oral anticoagulant benefit in atrial fibrillation depends on international normalized ratio time in therapeutic range
›› Vitamin D deficiency adversely affects cardiovascular health
›› Clopidogrel efficacy reduced in persons with CYP2C19 variants
›› Pharmacy's top ten news stories of 2008
›› Treat dyslipidemia in children with diabetes, but long-term data needed
›› Multiple courses of antenatal corticosteroids: Too much of a good thing?